家禽药物市场：依产品类型、依动物类型、按地区

Poultry Pharmaceuticals Market, By Product Type, By Animal Type, and By Region

出版日期: 2025年05月28日 | 出版商:

Coherent Market Insights | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

简介目录

家禽药物市场规模预计在 2025 年达到 87 亿美元，预计到 2032 年将达到 157 亿美元，2025 年至 2032 年的复合年增长率为 8.8%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	87亿美元
效能数据	从2020年到2024年	预测期	2025年至2032年
预测期：2025-2032年复合年增长率：	8.80%	2032年价值预测	157亿美元

肉类、鸡肉和鸡蛋等家禽产品在全球范围内被广泛消费。对这些产品的需求正在上升，此外，对动物蛋白的需求增加预计是预测期内推动家禽药品市场成长的主要因素。家禽数量的增加和禽病患病率的上升预计将推动通用疫苗的需求。由于人畜共通感染疾病的增加，对家禽疫苗的需求正在激增。家禽疫苗透过显着增强免疫系统来产生对抗入侵生物的抗体，有助于预防某些疾病。家禽疫苗在控制和预防家禽疾病方面发挥重要作用。大多数家禽疫苗是为对抗病毒性疾病而开发的。这些疫苗以各种形式给药，例如鼻内、口服、眼部、活疫苗、皮下和肌肉注射。

市场动态

主要市场参与者正致力于推出新型疫苗，以保护家禽免受马立克氏症的侵害，预计这将在预测期内推动全球灭活家禽药物市场的成长。例如，2020年，勃林格殷格翰（Boehringer Ingelheim）推出了VAXXITEK HVT+IBD+ND疫苗，该疫苗由德国一家以研发主导的企业集团组成，专注于创新医疗保健产品的发现、开发、生产和营销。勃林格殷格翰在其基地生产VAXXITEK HVT+IBD+ND疫苗，该基地每年开发超过600亿支家禽疫苗，供包括美国在内的60多个国家使用。

本研究的主要特点

本研究报告对全球家禽药品市场进行了详细分析，并以 2024 年为基准年，提供了 2025 年至 2032 年预测期内的市场规模和年复合成长率(CAGR)。
它还揭示了各个领域的潜在商机，并解释了该市场有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
它根据公司亮点、产品系列、关键亮点、财务表现和策略等参数，概述了全球家禽製药市场的主要企业。
本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
全球家禽製药市场报告迎合了该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
相关人员可以透过分析全球家禽药品市场所使用的各种策略矩阵来促进决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 8.7 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	8.80%	2032 Value Projection:	USD 15.7 Bn

Poultry products such as meat, chicken, eggs, and others are widely consumed globally. Demand for these products is on the rise, moreover, increasing demand for animal-based protein is a major factor, which is expected to drive growth of the poultry pharmaceuticals market over the forecast period. The increasing poultry population and the growing prevalence of avian diseases are anticipated to enhance the demand for poultry vaccines. There is a surge in demand for poultry vaccines because of the increasing number of zoonotic cases. Poultry vaccine helps prevent a specific disease by considerably accelerating their immune system to develop antibodies to battle against the invading organisms. Poultry vaccines play a major role in poultry disease control and prevention. The majority of poultry-killed vaccines are developed to fight against viral diseases. These vaccines are administered in different forms, such as nasal, oral, ocular, vivo, subcutaneous, and intramuscular.

Market Dynamics

Key market players are focusing on launch of new vaccine to protect poutry against Marek's Disease is expected to the global inactivated poultry pharmaceuticals market growth over the forecast period. For instance, in 2020, Boehringer Ingelheim, a research-driven group of companies dedicated to the discovery, development, manufacture and marketing of innovative health care products in Germany, launched the VAXXITEK HVT+IBD+ND vaccine to protect poultry against Marek's Disease, Newcastle Disease, and Infectious Bursal Disease (classic and variant types). Boehringer Ingelheim will produce VAXXITEK HVT+IBD+ND from its site which develops more than 60 billion doses of poultry vaccine a year for use in the U.S. and over 60 other countries.

Key features of the study:

This report provides an in-depth analysis of the global poultry pharmaceuticals market and provides market size (US$ Billion) and compound annual growth rate (CAGR) for the forecast period 2025-2032, considering 2024 as the base year.
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global poultry pharmaceuticals market based on the following parameters- Company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Bayer AG, Bimeda, Ceva Sante Animale, Elanco Animal Health (Eli Lilly and Company), Merck Animal Health, Merial Animal Health (Sanofi), Virbac, Boehringer Ingelheim, Zoetis, Inc., Pacific GeneTech, and Avivagen Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global poultry pharmaceuticals market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global poultry pharmaceuticals market.

Market Segmentation

Global Poultry Pharmaceuticals Market, By Product Type:
- Drugs
- VETRIMOXIN
- Other Drug Products
- Vaccines
- INNOVAX
- NOBILIS
- Poulvac
- Other Vaccine Products
- Feed Additives
- VIGOSINE
- Amnovit
- Other Feed Additives
Global Poultry Pharmaceuticals Market, By Animal Type :
- Chicken
- Turkey
- Duck
- Goose
- Others
Global Poultry Pharmaceuticals Market, By Region:
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Company Profiles
- Bayer AG
- Bimeda
- Ceva Sante Animale
- Elanco Animal Health (Eli Lilly and Company)
- Merck Animal Health
- Merial Animal Health (Sanofi)
- Virbac
- Boehringer Ingelheim
- Zoetis, Inc.
- Pacific GeneTech
- Avivagen Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product type
- Market Snapshot, By Animal Type
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaboration
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Poultry Pharmaceuticals Market, By Product Type, 2020 - 2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
  - VETRIMOXIN
  - Other Drug Products
Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
  - INNOVAX
  - NOBILIS
  - Poulvac
  - Other Vaccine Products
Feed Additives
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
- Segment Trends
  - VIGOSINE
  - ABnovit
  - Other Feed Additives

5. Global Poultry Pharmaceuticals Market, By Animal Type, 2020 - 2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Chicken
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Turkey
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Duck
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Goose
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2032, (US$ Bn)

6. Global Poultry Pharmaceuticals Market, By Region, 2020 - 2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
North America
- Market Size and Forecast, By Product Type, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, By Animal Type, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, By Country, 2020 - 2032, (US$ Bn)
  - U.S.
  - Canada
Europe
- Market Size and Forecast, By Product Type, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, By Animal Type, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, By Country, 2020 - 2032, (US$ Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Size and Forecast, By Product Type, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, By Animal Type, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, By Country, 2020 - 2032, (US$ Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Latin America
- Market Size and Forecast, By Product Type, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, By Animal Type, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, By Country, 2020 - 2032, (US$ Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Market Size and Forecast, By Product Type, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, By Animal Type, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, By Country, 2020 - 2032, (US$ Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Market Size and Forecast, By Product Type, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, By Animal Type, 2020 - 2032, (US$ Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, (US$ Bn)
  - North Africa
  - Central Africa
  - South Africa
  - Rest of Africa

7. Company Profiles

Bayer AG
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Bimeda
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Ceva Sante Animale
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Elanco Animal Health (Eli Lilly and Company)
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck Animal Health
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merial Animal Health (Sanofi)
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Virbac
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Boehringer Ingelheim
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Zoetis, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pacific GeneTech
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Avivagen Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies

8. Section

References
Research Methodology
About us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

家禽药物市场：依产品类型、依动物类型、按地区